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Lectins from dietary plants have been shown to enhance drug absorption in the gastrointestinal tract of rats, be transported trans-synaptically as shown by tracing of axonal and
dendritic paths, and enhance gene delivery. Other carbohydrate-binding protein toxins
are known to traverse the gut intact in dogs. Post-feeding rhodamine- or TRITC-tagged
dietary lectins, the lectins were tracked from gut to dopaminergic neurons (DAergic-N)
in transgenic Caenorhabditis elegans (C. elegans) [egIs1(Pdat-1:GFP)] where the mutant
has the green fluorescent protein (GFP) gene fused to a dopamine transport protein
gene labeling DAergic-N. The lectins were supplemented along with the food organism
Escherichia coli (OP50). Among nine tested rhodamine/TRITC-tagged lectins, four,
including Phaseolus vulgaris erythroagglutinin (PHA-E), Bandeiraea simplicifolia (BS-I),
Dolichos biflorus agglutinin (DBA), and Arachis hypogaea agglutinin (PNA), appeared
to be transported from gut to the GFP-DAergic-N. Griffonia Simplicifolia and PHA-E,
reduced the number of GFP-DAergic-N, suggesting a toxic activity. PHA-E, BS-I, Pisum
sativum (PSA), and Triticum vulgaris agglutinin (Succinylated) reduced fluorescent
intensity of GFP-DAergic-N. PHA-E, PSA, Concanavalin A, and Triticum vulgaris agglutinin decreased the size of GFP-DAergic-N, while BS-I increased neuron size. These
observations suggest that dietary plant lectins are transported to and affect DAergic-N
in C. elegans, which support Braak and Hawkes’ hypothesis, suggesting one alternate
potential dietary etiology of Parkinson’s disease (PD). A recent Danish study showed that
vagotomy resulted in 40% lower incidence of PD over 20 years. Differences in inherited
sugar structures of gut and neuronal cell surfaces may make some individuals more
susceptible in this conceptual disease etiology model.
Keywords: Caenorhabditis elegans, dopaminergic neurons, dopamine transporter, fluorescence, plant lectins
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INTRODUCTION

attach to carbohydrate receptors on epithelial cells to colonize
the GI and genito-urinary tracts. Some lectins are synergistically
toxic both locally and systemically to experimental animals (18).
Kidney bean lectin (PHA), for example, damages intestinal epithelial cells, causes bacterial overgrowth, and induces nutritional
disorders, effects which are preventable by inhibition with the
specific sugars that have competitive binding capacities to lectins
by sharing similar terminal structures (18, 32). Likewise, dietary
saccharides or glycoconjugates, such as probiotic agents and
milk oligosaccharides, may act as receptor analogs or decoys to
selectively and competitively reduce lectin binding (18, 33, 34).
Soybean lectin has shown potential anticarcinogenic effects (35).
Complex environmental factors play important roles for neurodevelopmental and neurodegenerative disorders, including PD
(36, 37). Controversial reports suggest that a higher prevalence
of PD occurs in vegetarians compared to omnivores (3, 38). In
equine Parkinsonism, consuming yellow star thistles (Centaurea
solstitialis) or Russian knapweed (Acroptilon repens) causes liquid
necrosis in the substantia nigra pars reticulata and the globus
pallidus by destroying DAergic-N, developing nigropallidal
encephalomalacia (NPE), and creating histopathological features
that resemble human idiopathic PD (39). These observations
suggest transport of toxic substances from the horse gut to brain
neurons. To date, however, in humans, epidemiology has not
proven dietary lectins to have a significant impact on neuronal
degenerative diseases. Signature pathologies of PD, e.g., Lewey’s
bodies and aggregated alpha-synuclein (α-SYN) occur in neurons
of the enteric nervous system of the GI wall, in addition to the
neurons of the central nervous system (CNS) (40). α-SYN also
aggregates in microglia and further leads to PD though the
detailed mechanism remains unclear (41, 42), while astrocytes
convert neurotoxin MPTP to its active metabolite MPP+ (43). The
findings reported here support Braak and Hawkes’ hypothesis
that the GI tract may be a potential site of neuronal invasion by
an “unknown etiologic agent,” potentially responsible for causing
some percentage of PD (40, 44–47). It is suggested herein that one
possible etiologic agent could be dietary lectins.
Caenorhabditis elegans has a high conservation (>65%)
of human disease-associated genes (48, 49). A total of eight
DAergic-N in the hermaphrodite C. elegans (50–52) respond
to signals from environmental mechano-sensory stimuli, e.g.,
exhausted food supply, which have offered molecular, genetic,
and behavioral tools to aid human disease studies (53–57). C.
elegans modulates locomotion behavior by using dopamine
and serotonin to mediate motor circuits in chemical synapses,
gap junctions, and neuromuscular junctions (58–60). Intestinal
muscle cells are innervated by pharyngeal motor neurons
and bioaminergic neurons via the preanal ganglia. Structures,
sensory-motor synapses, gap junction contacts, and activities all
resemble those in the mammalian GI tract (61, 62).
The features of the green fluorescent protein (GFP)-dopamine
transporter (DAT) fusion protein C. elegans [egIs1(Pdat-1:GFP)]
were evaluated by the numbers, fluorescent intensity, and sizes
of GFP-DAergic-N in this study. Meanwhile, TRITC-labeled
lectins were also followed post-feeding to establish the ability
of lectins to bind or penetrate the GI wall or nerve cells. The
question was whether dietary plant lectins can be transported

Could dietary plant proteins, such as lectins, traverse the gut
intact, with vesicular transfer to neurons and be transported
intact along axons to affect dopaminergic neurons (DAergic-N)
as one etiology of Parkinson’s disease (PD)? A recent Danish
study showed that patients who had vagal nerves removed
20 years ago had a 40% lower incidence of PD (1). Some reports
claim that vegetarians have higher rates of PD (2, 3). This study
uses C. elegans as a model to investigate dietary lectin transport
to DAergic-N.
Plant lectins were discovered over a century ago (4). Toxicity
of some lectins was first recognized, independently, by Bruylants
and Vennemann (5); Warden and Waddell (6) [described by
Oppenheimer (7) and Dixson (8)]. Lectins’ hemagglutination
properties were found by Stillmark (9), and a general recognition
of antigenicity by lectins was revealed by Paul Ehrlich in 1890
(10) who won a Nobel Prize in Physiology or Medicine 1908
“in recognition of their work on immunity”1. Thereafter, lectins’
“immune recognition” was used for immunological research [see
Textbook of Military Medicine (11)]. In 1919, Sumner crystallized (Canavalia ensiformis, Concanavalin A) (12). A half century
later, investigators began to determine ABO-blood subtypes
due to their sugar-binding properties, and the name “lectins”
was formally coined (13, 14). Recent studies report that lectins
play important roles in plant defense (15) and legume–rhizobial
interactions (16).
Plants contain glycoprotein-lectins (“non-immune sugarbinding proteins”) in seeds, fruits, and nuts (2), and recognize
and reversibly bind specific carbohydrates (17). They are involved
in plant defense (15) and legume–rhizobia (16). Upon consumption by animals, they resist gut proteolytic enzymes, maintaining
function under adverse gastrointestinal (GI) conditions (18,
19). They can penetrate the GI tract wall by endocytosis (20),
probably by first binding a carbohydrate lectin receptor (21).
Astonishingly, intact lectins can transfer trans-synaptically in an
antegrade and/or retrograde fashion along nerve fibers (17, 22).
Their medical importance is increasingly being recognized by
being conjugated with drugs for better drug absorption from the
GI tract (21, 23–25). Particularly relevant to the current studies,
lectins have been utilized extensively for neuronal tracing studies
[see review (22, 26)]. Ricin (Ricinus communis) as an extremely
cytotoxic lectin has been studied extensively for its function in
retrograde transport, via a galactose-binding β-chain-mediated
endocytosis, following translocation of the enzymatically active
and toxic A-chain, from the endosomes to the Golgi apparatus
(27, 28). This property has been utilized for treatment of malignancies at low doses (29, 30). Lectins have also been conjugated
with DNA for enhanced nervous system gene delivery (31). Most
dietary plant lectins resist gut proteolytic enzymes and maintain
function under usually adverse conditions for proteins (18, 19).
Non-toxic lectins, such as tomato lectin and wheat germ agglutinin, are suggested to show growth factor activity in the GI tract
(18). Bacteria or parasitic protozoa, through their own lectins,
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Fluorescent Microscopy

to, and impair or alter apparently DAergic-N. Differences in
inherited sugar structures of gut and neuronal cell surface may
make some individuals more susceptible in this conceptual
disease model.

The GFP-DAergic-N were identified by FTIC filter (480Ex/520Em)
and the number of GFP-DAergic-N counted. Fluorescent intensity
of GFP-DAergic-N and their average sizes (square micrometer)
were determined by NIS-Elements Advanced Research (version
3.22.11) and compared among the following groups: control and
lectins. Fluorescent intensity of rhodamine-lectins was determined by a TRITC filter (580Ex/620Em) to assess co-localization.
The magnitude of the effect(s) of the lectin on the DAergic-N, the
number, fluorescent intensity (arbitrary unit), and sizes (square
micrometer) of GFP-DAergic-N were determined and compared
among each group. Co-localization was initially identified with
an inverted microscopy (Nikon, Eclipse Ti–S, Japan) and then
confirmed at a Z-axle with laser scanning microscopy (Leica, TCS
SP5, Germany).

MATERIALS AND METHODS
Caenorhabditis elegans (egIs1[Pdat-1:GFP]) that express GFP in
the eight DAergic-N (63, 64) and the standard food Escherichia
coli (E. coli) were obtained from C. elegans Genetics Center (CGC,
MN). The C. elegans model does not require regulation of the
Institutional Animal Care and Use Committee (IACUC).

C. elegans Culture

Caenorhabditis elegans were egg-synchronized, fed ad libitum
with LB broth (200 μl/agar plate or 250 μl/well) containing
OP50 5 × 108–5 × 1011 cfu/ml (65), grown in nematode growth
media (NGM) agar plates (∅35 mm, 3 ml) and transported to
new plates every other day (n = 20). Or, seeded in 96-well plate
(n = 10–15/well) grown in liquid culture supplemented with
fluorodeoxyuridine (FUDR, 0.6 mM/30 μl) (66). The plate was
tape sealed, bagged, and covered with aluminum foil, and kept in
a 20°C low temperature incubator (Revco Tech., Nashville, NC,
USA) throughout the experiments.
All treatments were applied at day 3 after hatching. Four
dose–responses of nine lectins were obtained for each culture
condition in a dark room. Control animals were fed with OP50.
Experimental groups were fed TRITC/rhodamine-conjugated
lectins. The lectins were incorporated into feeding medium with
OP50. Two hundred microliter treatments were added into each
fresh agar dish prior to the transfer or 5 μl/well/week to liquid
culture. Each group of nematodes was collected and fixed by
15–20 days for the agar dish culture as previously described (67),
after the first week for the liquid culture.

Solutions and Chemicals

Standard NGM agar plates (g): NaCl 3.0 g, Bacto-agar (Becton,
MD, USA) 20 g, Bacto-peptone 2.5 g (Becton, MN, USA),
Cholesterol solution 0.1% (0.005/ml 95% ethanol), and dH2O
975ml were mixed. Additions to the autoclaved solution (M):
CaCl2 1.0 1 ml, MgSO4 1.0 1 ml, KPO4 pH6 1.0 25 ml. LB Broth:
25.0 g, dH2O 1 l (autoclave). S-basal solution (M): NaCl 0.1, KPO4
pH6 0.05, Cholesterol 0.1%, was autoclaved. PBS (millimolar):
115 NaCl, 75 Na2HPO4•7H2O, and 7.5 KH2PO4, pH 7.4.

Statistical Analyses

Analyses were carried out using SAS/STAT® software, Version 9.4
of the SAS System for Windows (Cary, NC, USA). All results were
expressed as mean ± SEM. Survival curves were displayed by
binomial probabilities obtained from logistic regression models
as surrogates for survival probabilities and mean lifespan was
estimated via Kaplan–Meier (log rank). ANOVA models were
used to analyze fluorescence intensity data. For each group, 20
animals were analyzed for agar culture and 10–15 animals were
analyzed for liquid culture. Statistical significance was defined as
P < 0.05.

Culture of Escherichia coli (OP50)

OP50 (10 μl) and streptomycin (10 μl/ml) were mixed with LB
Broth (100 ml, see below) for 16 h at 37°C in an incubator and
stored at 4°C for up to 3 months.

RESULTS

Select Lectins

Commercially available plant lectins conjugated to TRITC or
rhodamine were from EY labs (San Mateo, CA, USA), Vector
Labs (Burlingame, CA, USA), or Sigma-Aldrich (St. Louis, MO,
USA). Doses of lectins (millimolar) used were comparable to
those used in published work in neuronal tracing (17, 22, 26).

Diets supplemented with varying concentrations of rhodaminelabeled lectins Phaseolus vulgaris erythroagglutinin (PHA-E),
Bandeiraea simplicifolia (BS-I), or Dolichos biflorus agglutinin
(DBA) in agar dish, or TRITC-conjugated Arachis hypogaea
agglutinin (PNA) in liquid culture were fed to C. elegans, and
subsequently detected by fluorescence microscopy associated
with GFP-DAergic-N (Table 1). The only explanation for this
observation is that rhodamine- or TRITC-labeled lectins traveled
in some manner from the gut to the neurons. We observed that
some lectins had the following effects: (a) reducing the number
of DAergic-N, (b) decreasing fluorescent intensity of GFPexpressing neurons (less GFP-DAT), or (c) altering neuron size.
GSL-I, Con A, Pisum sativum (PSA), WGA, or S-WGA were not
detected as transported to neurons, but nevertheless, some had
significant effects on the neuron measurements, possibly indicating that undetectable amounts of these lectins caused the effects,

Average Probability of Survival Assay

All average probability of survival (APS) assays was conducted in
liquid culture (96-well plate). The animals were synchronized and
seeded into each well of a plate (n = 10–15) and OP50 was added
to each well. Thirty microliters (0.6 mM) of FUDR were added to
each well to sterilize the animals. Four different treatments of lectins (50 μl/treatment, n = 6 row) were added. The plate was then
covered with aluminum foil. The whole procedure was performed
in a dark room to prevent bleaching of fluorophores. The survival
animals were counted every other day until all were dead.
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TABLE 1 | Lectins detected in the neurons by co-localization.
Lectins
Phaseolus vulgaris (PHA-E)-rhodamine

Bandeiraea simplicifolia (BS-I)-TRITC
Dolichos biflorus (DBA)-rhodamine

Dose (mM)

GFP #

GFP size

2.0 × 10−4
6.0 × 10−4
2.0 × 10−3

↓

P > 0.05
P > 0.05
P < 0.01

↓

P < 0.01
P < 0.01
P < 0.01

↓

P > 0.05
P > 0.05
P < 0.01

5.3 × 10−4
1.8 × 10−3

↓

P > 0.05
P > 0.05

↓

P < 0.01
P < 0.01

↑

P < 0.01
P < 0.01

↔

P > 0.05

↔

P > 0.05

↔

P > 0.05

↓

P > 0.05
P > 0.05
P < 0.01

↓

P < 0.01
P > 0.05
P < 0.01

↓

P > 0.05
P > 0.05
P < 0.01

1.0 × 10−3
3.3 × 10−3

Arachis hypogaea agglutinin (PNA)-TRITC

GFP intensity

1.8 × 10−5
5.4 × 10−5
1.8 × 10−4

↓ Decreasing trend.
↑ Increasing trend.
↔ No significant alternation.

or that some unexplained secondary effect of the lectins caused
pathological effects.

was similar to aged animals and 65–80% co-localized with
DBA-rhodamine (Figures 4E,G). The size of GFP-DAergic-N
was reduced in a dose-dependent trend at higher doses of
DBA-rhodamine (P > 0.05) (data not shown). The fluorescence
intensity and size of GFP-DAergic-N in 2-day-old animals were
similar to aged animals (Figure 4E,F). The APS was increased at
lower doses of DBA, and decreased at higher doses (Figure 4J).
Mean lifespan was reduced at the highest dose (1.8 × 10−4 mM)
from 19 to 11 days (−43%, P < 0.05, Figure 4K). Although some
experiments were done adding lectin-specific inhibitory sugars to
the medium for mitigation of the lectin effects, very high concentrations, up to 200 mM were needed to show any effects, and there
were concerns about pleiotropic effects of these sugars fed at high
amounts. For example, the animals died in presence of GalNAc
(50 mM) within 2 days, possibly because of uridine diphosphate
(UDP) depletion (68). Another example of problems with dosing
live animals with dietary sugars to offset the lectin effects was that
the mean lifespan was reduced by galactose (200 mM) from 19 to
12 days (−36%, P < 0.05, Figure 5H). Use of high concentrations
of sugars on whole animals had their own effects. Therefore, we
have not included data herein using lectin-inhibitory sugars.
Arachis hypogaea agglutinin (PNA)-TRITC co-localized
with GFP-GAergic neurons after 1-week treatment (1.8 × 10−5,
5.4 × 10−5, 1.8 × 10−4 mM, Figure 5). The size and intensity of GFPGAergic neurons was not altered. The number of GFP-GAergic
neurons was increased at low dose (1.8 × 10−5 mM, P < 0.05) and
reduced at higher doses. APS was dose-dependently reduced at
all doses (Figure 5G). Mean lifespan was reduced by higher doses
(5.4 × 10−5 mM and 1.8 × 10−4 mM) from 19 to 15 and 14 days
(−24 and −27%, P < 0.05, Figure 5H), with an increase at the
highest dose (1.8 × 10−4 mM) from 12 to 16 days (33%, P < 0.05).

Lectins Co-Localized with the
GFP-DAergic Neurons

Phaseolus vulgaris erythroagglutinin-rhodamine co-localized
with GFP-DAergic-N within 2 weeks after feeding (Figure 1).
The number of GFP-DAergic-N was reduced in a dose-dependent
manner (P < 0.01, Figure 1D). PHA-E-rhodamine co-localized
to a subgroup of GFP-DAergic-N (Figure 1B). The fluorescence
intensity of GFP-DAergic-N was decreased dose-dependently
(P < 0.01, Figure 1E), suggesting a diminution of the GFP-DAT.
The average size of GFP-DAergic-N was also reduced at the highest dose (P < 0.01, Figure 1F). PHA-E-rhodamine fluorescence
image size was inversely proportional to the number, average
intensity, and average size of the GFP-DAergic-N. The APS was
increased dose-dependently (Figure 1G). The mean lifespan was
increased at a medial dose (5.4 × 10−5 mM) from 17 to 23 days
(39%, P < 0.05, Figure 1H).
Bandeiraea simplicifolia–TRITC (Sigma-Aldrich) co-localized
with GFP-DAergic-N (Figure 2). The number of the GFPDAergic-N was reduced in a dose-dependent trend (P > 0.05,
Figure 2D). The fluorescence intensity of GFP-DAT protein in
DAergic-N was dose-dependently reduced (P < 0.01, Figure 2E).
The size of GFP-DAergic-N was elevated (P < 0.01, Figure 2F).
The APS was dose-dependently decreased at all doses (Figure 2G).
Mean lifespan was decreased at the highest dose (1.8 × 10−4 mM)
from 17 to 10 days (−37%, P < 0.05, Figure 2H).
Griffonia Simplicifolia I (GSL-I)-rhodamine (Vector) did not
show fluorescence co-localization, and did not affect the number
or size of GFP-DAergic-N (Figures 3A,C). The fluorescence
intensity of the neuron was increased at all doses (Figure 3B).
Dolichos biflorus agglutinin-rhodamine co-localized with
GFP-DAergic-N within 3 days after feeding. In aged nematodes,
50% of neurons co-localized with DBA-rhodamine at high doses
(Figure 4). The number (Figure 4G), fluorescence intensity
(Figure 4H), or size (Figure 4I) of DAergic-N were not altered
(P > 0.05). In 2-day-old animals, the number of GFP-DAergic-N
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Lectins Altered the GFP-DAergic Neurons
Without Co-Localization

Lectins that alter number, GFP-intensity, or size of neurons
without observed co-localization are given in Table 2.
Pisum sativum-rhodamine feeding did not reduce the number of GFP-DAergic-N (P > 0.05, Figure 6A). However, the
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FIGURE 1 | Phaseolus vulgaris (PHA-E)-rhodamine co-localized and diminished GFP-DAergic neurons in C. elegans post feeding. (A) GFP-DAergic
neurons. (B) PHA-E-rhodamine in several GFP-DAergic neurons. (C) Merged (A,B) showing co-localization of the PHA-E-rhodamine with GFP-DAergic neurons.
(D) Dose-dependent reduction of the number of GFP-DAergic neurons per animal: 4.4 ± 0.3 (2 × 10−3 mM, n = 3, P < 0.01). (E) Dose-dependent reduction of
fluorescence intensity per GFP-DAergic neurons: 5,837 ± 556 (2 × 10−4–2 × 10−3mM, n = 3, P < 0.01). (F) Size reduction of GFP-DAergic neurons: 3.3 ± 0.4 μm2
(2 × 10−3 mM, n = 3, P < 0.01). (G) The APS was increased dose-dependently. (H) Mean survival time of each group. *indicates statistical significance.

of GFP-DAergic-N in liquid culture (P > 0.05, Figure 7D),
increased the intensity at high dose (1.9 × 10−4 mM, P < 0.05,
Figure 7E), and decreased the size of neuron at middle dose
(5.7 × 10−5 mM, P < 0.05, Figure 7F). The APS was increased
at all doses (Figure 7G). Con A did not affect the mean lifespan
(Figure 7H).
Triticum vulgaris (WGA)-rhodamine or WGA-TRITC was not
detected as transported (Figure 8). The intensity of DAergic-N
was increased (P < 0.05, Figure 8A), while the size of the neurons
was decreased (P < 0.05) at the highest dose (4.6 × 10−4 mM,
Figure 8B). The APS was increased at all doses (Figure 8D).
Mean lifespan was increased at the highest dose (4.6 × 10−4 mM)
from 20 to 24 days (22%, P < 0.05, Figure 8E).
Triticum vulgaris (Succinylated) S-WGA-TRITC feeding had
a similar effect as WGA-rhodamine. The number of DAergic-N
did not show a significant change (Figure 9A), however, fluorescent intensity of the GFP-DAergic-N was decreased (P < 0.05,

fluorescence intensity (P < 0.001) and size (P > 0.05) of GFP-DAT
in DAergic-N were dose-dependently decreased with PSA feeding (P = 0.8, Figures 6B,C). In liquid culture, the number of the
GFP-DAergic-N was not altered (Figure 6D), the intensity was
diminished at high dose (4.3 × 10−4 mM, P < 0.05, Figure 6E),
and the size was reduced at low dose (4.3 × 10−5 mM, P < 0.05,
Figure 6F). The APS was increased at all doses (Figure 6G).
Mean lifespan was increased by lower doses (4.3 × 10−5 mM
and 4.3 × 10−4 mM) from 22 to 27 days (22 and 23%, P < 0.05,
Figure 6H).
Concanavalin A (Con A)-TRITC appeared to have a mild effect
on the GFP-DAergic-N reducing the number of GFP-DAergic-N
in a dose-dependent trend (Figure 7A). The fluorescence
intensity of GFP-DAT protein image in DAergic-N was dosedependently increased by Con A feeding (P < 0.05, Figure 7B).
The apparent size of GFP-DAergic-N was significantly reduced
(P < 0.05, Figure 7C). Con A-TRITC did not alter the number
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FIGURE 2 | Bandeiraea simplicifolia (BS-I)-rhodamine co-localized with GFP-DAergic neurons: (A) GFP-DAergic neurons. (B) BS-I-rhodamine in
GFP-DAergic neurons (5.26 × 10−4 or 1.75 × 10−3 mM). (C) Merged (A,B) showing co-localization of the BS-I-rhodamine with GFP-DAergic neurons. (D) Dosedependent reduction of GFP-DAergic neurons per animal: 7.0 ± 1.0 (1.75 × 10−4 mM) or 6.7 (1.75 × 10−3 mM) (n = 3, P > 0.05). (E) Reduction in fluorescence
intensity per GFP-DAergic neuron (up to 60%): 4,468 ± 332 or 5,166 ± 300 (5.3 × 10−4 or 1.75 × 10−3mM, n = 3, P < 0.01). (F) The size of GFP-DAergic neurons
was elevated dose-dependently from 8.0 ± 0.8 to 20.1 ± 1.7 μm2 (5.26 × 10−4) or 21.4 ± 2.5 μm2 (1.57 × 10−4) (n = 3, P < 0.01). (G) The APS was dosedependently decreased at all doses. (H) Mean survival time of each group. *indicates statistical significance.
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FIGURE 3 | Griffonia simplicifolia I (GSL-I)-rhodamine appeared to affect the GFP-DAergic neurons. (A) GSL-I did not affect the number of the
GFP DAergic neuron. (B) GSL-I increased fluorescence intensity of the neuron at all doses (P < 0.05). (C) GSL-I did not affect neuron size. *indicates
statistical significance.

FIGURE 4 | Dolichos biflorus agglutinin (DBA)-rhodamine in C. elegans co-localized with GFP-DAergic neurons of aged and young nematodes (L3).
GFP-DAergic neurons in aged animals (A) or young animals (D). DBA-rhodamine in GFP-DAergic neurons in aged animals (1.0 × 10−3 or 3.33 × 10−3 mM) (B) or
young animals (E). Merged (A,B) showing co-localization of the DBA-rhodamine with GFP-DAergic neurons in aged animals (C) or young animals (F). (G) The
number of DAergic neurons was not altered (7.5, n = 5, P > 0.2) and 50% of them were co-localized with DBA-rb (1.0 × 10−3 or 3.33 × 10−3 mM, n = 3) in the aged
animals. (H) The fluorescence intensity per GFP-DAergic neuron. (I) The size of the GFP-DAergic neurons was not changed. These observations were similarly seen
in young animals. (J) The APS was increased at lower doses of DBA, and decreased at higher doses. (K) Mean survival time of each group. *indicates statistical
significance.
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FIGURE 5 | Arachis hypogaea agglutinin (PNA)-TRITC post-feeding C. elegans co-localized with GFP-DAergic neurons (Leica, TCS SP5, Germany).
(A) GFP-DAergic neurons (green), (B) PNA-TRITC in the neuron (red), (C) Co-localization of the GFP-DAergic neurons in merged (A,B) (yellow). (D) Number of
GFP-DAergic neurons was increased at low dose (P < 0.05). (E) The intensity of GFP-DAergic neurons was not altered. (F) The size of GFP-DAergic neurons was
not altered. (G) APS was dose-dependently reduced at all doses. (H) Mean survival time of each group. *indicates statistical significance.

DISCUSSION

Figure 9B). The size of GFP-DAergic-N was slightly reduced in
a dose-dependent trend (P = 0.4, Figure 9C). In these cases, it is
not clear whether the lectin has some undefined indirect effect
or that there is a direct effect by undetectable amounts of lectin.
S-WGA-TRITC feeding C. elegans did not show co-localization in
liquid culture. The number of the GFP-DAergic-N was decreased
at lower doses (4.6 × 10−5 mM and 1.4 × 10−4 mM, P < 0.05,
Figure 9D). The fluorescent intensity of GFP-DAergic-N was
increased at all doses (P < 0.05, Figure 9E). The size of GFPDAergic-N was decreased at all doses (P < 0.05, Figure 9F). The
APS was increased at a low dose, and decreased does-dependently
at higher doses (Figure 9G). The mean lifespan was increased at a
low dose (4.6 × 10−5 mM) from 21 to 23 days (9%, P < 0.05), and
decreased at the highest dose (4.6 × 10−4 mM) to 12 days (−43%,
P < 0.05, Figure 9H).
Frontiers in Nutrition | www.frontiersin.org

Nine examined plant dietary lectins were conjugated to TRITC or
rhodamine. Lectins were tested in the in vivo C. elegans (egIs1[Pdat1:GFP]) model. An elevated GFP-DAT that is expressed under
control of the DAT gene promoter shows enhanced DAT expression and trafficking by the promoter, transcription factor, and
nuclear receptor (69).
Carbohydrate-binding protein toxins are known to survive
and traverse the gut intact, as an acutely toxic substance and can
induce serious life-threatening illness in humans and animals.
Distance pathogenicity of botulinum toxin, as well as cholera
toxin, impairs the CNS (70). The present study was aimed at a
new, surprising property of lectins based upon the hypothesis
that lectins may be transported directly by gut absorption to local
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TABLE 2 | Lectins alter number, GFP-intensity, or size of DAergic neurons without observed co-localization.
Fluorescence lectins

Dose (mM)

GFP #

GFP intensity

GFP size

5.2 × 10−4
1.7 × 10−3
5.2 × 10−3

↔

P > 0.05

↑

P < 0.05

↔

P > 0.05

Pisum sativum (PSA)-rhodamine (agar)

8.7 × 10−4
8.7 × 10−3

↔

P > 0.05

↓

P < 0.001

↓

P > 0.05

Pisum sativum (PSA)-rhodamine (liquid)

4.3 × 10−5
↔

P > 0.05

3.8 × 10−4
1.2 × 10−3
3.8 × 10−3

↔

P > 0.05

Concanavalin A (Con A)-TRITC (liquid)

1.9 × 10−5
5.7 × 10−5
1.9 × 10−4

↔

Triticum vulgaris (WGA)-TRITC

4.6 × 10−5
1.4 × 10−4
4.6 × 10−4

Triticum vulgaris (Succinylated) S-WGA-TRITC (agar)
Triticum vulgaris (Succinylated) S-WGA-TRITC (liquid)

Griffonia simplicifolia I (GSL-I)-rhodamine

↔

P > 0.05

↓

P > 0.05

↔
↓

P > 0.05
P > 0.05

↔
↔

P > 0.05
P > 0.05

↔

P > 0.05

↑

P < 0.05

↓

P > 0.05

P > 0.05

↔
↔
↑

P > 0.05
P > 0.05
P < 0.05

↔
↓
↔

P > 0.05
P > 0.05
P > 0.05

↔

P > 0.05

↔
↔
↑

P > 0.05
P > 0.05
P < 0.05

↓

P < 0.05

1.1 × 10−3
1.1 × 10−2

↔

P > 0.05

↓

P < 0.05

↔

P > 0.05

4.6 × 10−5
1.4 × 10−4
4.6 × 10−4

↓
↓
↔

P < 0.05
P < 0.05
P > 0.05

↑

P < 0.05

↓

P < 0.05

1.3 × 10−4
4.3 × 10−4
Concanavalin A (Con A)-TRITC (agar)

↓ Decreasing trend.
↑ Increasing trend.
↔ No significant alternation.

neurons and transported axonally to distal neurons where they
have an anatomical and potentially a physiological pathophysiological effect. Fluorescent intensity and co-localization of lectins
was observed to suggest transport to GFP-DAergic-N. Number
and area changes of GFP-dopamine receptor fluorescence in
DAergic-N were observed to be an effect of the lectins. For the
fact that multiple system atrophy features the accumulation of
α-SYN in glial cytoplasmic inclusions (71–73), involvement of
other pathways such as indirect effects by interaction of lectins
with glial cells that affected DAergic-N may be possible. Lectins
have been used for histochemistry and neuronal tracing only,
but were not previously associated with neuronal toxicity (26,
74, 75).

to be detectable may have been missed, the lectin may have been
partially degraded, losing the fluorophore, but still retaining
neuron-effective activity, or, more likely, undetectable levels of
the lectin have observable activities. Future studies with ELISA,
other immunocytochemical studies or radiolabeling may confirm
the transport of small amounts of these specific lectins where an
effect is observed without fluorescence co-localization.

Lectin-Caused Differences in the Number
of GFP-DAergic Neurons

Four lectins [GSL-I (BSL I), PHA-E, Con A, and PSA] reduced
the number of DAergic-N, with GSL-I having the greatest effect.
Toxicity of some lectins and newly discovered side effects of
ingestion of PHA and WGA lectins in human and animals have
been observed, mitigated by sucrose feeding (76–78). In the
present study, PHA-E-rhodamine appeared to be transported
intracellularly, probably by axonal transport after ingestion, to C.
elegans GFP-DAergic-N causing a reduction in their number. This
reduction was inversely proportional to the size of the observed
image of PHA-E-rhodamine fluorescence co-localized with the
neurons. Thus, the greatest area of PHA-E-rhodamine co-stains
with the lowest observed number of GFP-DAergic-N. In addition, both fluorescence intensity and size of the GFP-DAergic-N
were significantly reduced, suggesting a possible toxic effect of
cytoplasmic PHA-E. This observation is in agreement with other
studies showing that PHA can damage intestinal epithelial cells
(32, 78), which was prevented or reversed by a PHA-E inhibitor
sucrose (78). Interestingly, PHA-E did not show a significant

The Occurrence and Intensity of Individual
Fluorescently Labeled Lectins in GFPDAergic-N Detected by Co-Localization

Four lectins (PHA-E, BS-I, PNA, or DBA) appeared to co-localize
with a subgroup of GFP-DAergic-N, while some other lectins had
effects where co-localization was not observed. Because some
effects were seen in neurons where lectins were not detected,
this may be due to undetectable amount of transported lectin,
or some unexplained indirect effect. Thus, the number and GFPDAT image of neurons were also evaluated, even when the fed
lectin was not detected in the neurons. The lack of observation
of fluorescence in the neurons using other fed lectins (which,
however, seemed to affect these neurons) may be due to a variety
of characteristics. For instance, a critical window for the lectin
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FIGURE 6 | Pisum sativum (PSA)-rhodamine affected the GFP-DAergic neurons in C. elegans. (A) The number of GFP-DAergic neurons per animal was not
reduced overall (8.70 × 10−4–8.7 × 10−3 mM, n = 6, P > 0.05). (B) The fluorescence intensity of GFP-DAergic neurons was decreased at high dose (651 ± 61,
8.7 × 10−3 mM). (C) The size of GFP-DAergic neurons appeared to be reduced at high dose from 18.4 ± 0.9 μm2 (control) to 12.9 μm2 (8.70 × 10−4 mM, n = 3,
P > 0.05) in a dose-dependent trend. Direct co-localization of PSA-rhodamine with GFP-DAergic neurons was not detected. (D) PSA alone did not affect the
number of the neurons. (E) PSA decreased the intensity of DAergic neurons at the highest dose (P < 0.05). (F) PSA decreased the size of the DAergic
neurons at lowest dose (P < 0.05), which was mitigated at the higher dose (P > 0.05). (G) The APS was increased at all doses. (H) Mean survival time of each
group. *indicates statistical significance.

decrease in the number and size of GFP-neurons in C. elegans but
demonstrated decreased expression of GFP-DAT fluorescence
intensity. PSA, in some studies, has been shown to be essentially
non-toxic in mice both in vivo and in vitro (79). However, shortterm toxicity measurements in these studies do not include more
subtle, possible long-term effects of neuronal damage.

in the present study, and in other laboratories, in the in vivo rat
gut lumen, reduced expression of heat shock proteins resulting
in lowered protection and greater permeability of epithelial cells.
WGA also increases thrombin in human platelets, and escalates
adipogenesis in mesenchymal cells of the mouse limb bud in vitro
by unknown mechanisms (25, 77, 80, 81).
In liquid culture, individual lectins affect the number and
intensity of GFP-DAergic-N in a different manner. GSL-I, Con A,
WGA, and PSA mildly affected the number of GFP-DAergic-N.
The intensity of GFP-DAergic-N was increased by GSL-I, Con
A, and WGA, while decreased by PSA. The number of GFPDAergic-N was reduced, while the intensity of GFP-DAergic-N
was increased by S-WGA in lower doses. PNA did not affect the
intensity of the GFP-DAergic-N, while increased the number of
neurons at lower doses.

Lectin Feeding Effects on the Fluorescent
Intensity of GFP-DAergic Neurons

Three lectins (PHA-E, PSA, or S-WGA) reduced GFP-DAT fluorescence in DAergic-N suggesting damage to DAT, while BS-I,
GSL-I, or Con A induced an increase indicating a promotion of
DAT in the DAergic-N. WGA slightly reduced the fluorescent
intensity of GFP-DAT in DAergic-N, while DBA was inactive.
Although WGA did not affect the number of GFP-DAergic-N
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FIGURE 7 | Concanavalin A (Con A)-TRITC in C. elegans appeared to have a mild effect on the GFP-DAergic neurons. (A) The number of GFP-DAergic
neurons per animal was slightly reduced at the high dose (7 ± 0.4, P > 0.05). (B) The fluorescence intensity per GFP-DAergic neuron was dose-dependently
increased from 691 ± 45 (control, n = 3) to 942 ± 118 (3.84 × 10−3 mM, n = 4, P < 0.05). (C) The size of GFP-DAergic neurons was significantly reduced from
21.4 ± 1.8 μm2 (control) to 15.1 ± 0.7 μm2 (1.15 × 10−3 mM, n = 4, P < 0.05). Direct co-localization of Con A-TRITC with GFP-DAergic neurons was not detected.
In liquid culture, Con A-TRITC in C. elegans appeared to have a mild effect on the GFP-DAergic neurons. (D) The number of the GFP-DAergic neuron was not
affected (P > 0.05). (E) The fluorescent intensity of the DAergic neuron was increased at the highest dose (P < 0.05). (F) The area of GFP-DAergic neurons was
decreased at middle dose (P < 0.05). (G) The APS was increased at all doses. (H) Mean survival time of each group. *indicates statistical significance.

Sizes of GFP-DAergic Neurons

sharing common features with protein phosphorylation [see
review (82)]. Although very difficult to detect due to substoichiometric amounts, O-GlcNAc occurs exclusively within the
nuclear and cytoplasmic compartments of the cell and responds
to external signaling, such as mitogen or antigen activation, by
altering Ser- and Thr-phosphoprotein profiles (83–84). The protein modification is modulated by O-GlcNAcase and O-GlcNAc
transferase, and even glucose levels modulate the O-GlcNAc
cycling rate. Characteristics of half-life in O-GlcNAc cycling
(≤1 min) have been linked closely to diabetes, cardiovascular
disease, neurodegenerative disorders, and cancer. Many protein
O-GlcNAc modifications occur in nucleocytoplasmic compartments across plant and animal species, including humans [see
review (82)]. WGA and other GlcNAc binding lectins, if present
in the cytoplasm, may affect this balance (our hypothesis). PNA

PHA-E or Con A significantly diminished the size of GFPDAergic-N, while BS-I, PSA, or S-WGA slightly reduced the size.
Whether these effects signify damage to the neurons is not known.
Increased neuron size of a subgroup of GFP-DAergic-N, however,
was also observed with DBA or WGA, which may have promoted
DAT expression, however, whether decrease or increase in the
apparent size of neurons has a physiological effect, or indicates
that lectin-mediated damage is not yet known.
The effect of lectins on the number of GFP-DAergic-N
appeared in the following order PHA-E > GSL-I > BS-I > Con
A > PSA > S-WGA. An elevation effect of lectins seemed to be in
the order of DBA > BS-I > WGA > GSL-I, and ConA. It is now
well known that O-linked β-N-acetylglucosamine (O-GlcNAc)
is a common epitope on cytoplasmic and some nuclear proteins
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FIGURE 8 | Triticum vulgaris (WGA)-rhodamine affected the intensity and area of DAergic neurons in liquid culture. (A) WGA did not affect the number
of DAergic neurons (B) WGA increased the intensity of the GFP-DAergic neurons. (C) The area of the DAergic neurons was reduced at all doses (P < 0.05). (D) The
APS was increased at all doses. (E) Mean survival time of each group. *indicates statistical significance.

strengthens extracellular matrixes by promoting production of
proteoglycan in mouse chondrocytes in vitro (81). Similar to
PNA, Con A has also been reported to strengthen extracellular
matrixes in mouse chondrocytes in vitro (81). In our study, Con
A altered GFP-DAergic-N by reducing the area of GFP-DAT
fluorescence.
Some specific beneficial activities of a variety of lectins have
been reported (81, 85). In our studies, DBA was observed in the
GFP-DAergic-N that had the effect of increasing the observed
area of the GFP-labeled DA transporter. This increase may suggest enhanced DAT expression and trafficking, where GFP is
expressed under the DAT promoter (69, 86). A major adverse
effect of DBA lectin has not been reported elsewhere. In fact, DBA
significantly facilitates cartilagenesis and osteogenesis in mouse
limb bud mesenchymal cells in vitro (81).
BS-I and GSL-I displayed similar activities. Significantly, BSI
I dose-dependently reduced the intensity of GFP-DAergic-N.
Functionally, BS-I containing 5-Hydroxytryptophan (5-HTP),
a catecholamine neurotransmitter, only binds to a subgroup of
small dorsal root ganglion neurons, which are of the C-nociceptor
type (C-fiber nociceptive or unresponsive) neurons. These
C-nociceptor neurons mediate visceral pain and express receptors to BS-I isolectin-B4 (IB4) (87–89). BS-I may increase
thrombin in human platelets (80). One possible mechanism that
might be related is over-excitation of neurons caused by excessive glutamate neurotransmission being neurotoxic, which may
cause neuronal death (90). Indeed, glutamatergic stimulation
may indirectly induce DAergic neuronal death via unbalanced
calcium homeostasis and oxidative stress, in vitro or in vivo (91).

Frontiers in Nutrition | www.frontiersin.org

Some of these systems could be altered by either sugar-binding or
other unexplored properties of lectins.
In liquid culture, PSA, Con A, WGA and S-WGA decreased
the area of GFP-DAergic-N. GSL-I and PNA did not show significant change.

Elevated Fluorescent Intensity and Size
of DAergic Neurons

These alterations may reflect a relationship with the insulin
receptor and DAT. Glucose provides a vital energy source for
brain and clearly modulates neuronal function (92, 93). In C.
elegans, hyperglycemia reduces APS, related to human diabetes.
These relationships in our study, however, may represent some
signaling interaction of glycemia/insulinemia and DAT. As with
other catecholamine neurotransmitters, inhibitory neurotransmitters are inversely proportional to glycemia, and DA kinetics is
sensitive to hypoglycemia in a complex manner (94). In rodents,
insulin receptors and DAT are densely present in substantia nigra,
insulin may increase DAT mRNA expression, and glycemic index
is inversely associated with the risk of PD (95, 96).

Lectins Affect Average Probability of
Survival of C. elegans

Lectins can be categorized into three groups based on their effects
on APS of C. elegans. (1) PHA-E, DBA, and S-WGA showed
J-shaped effects on APS that was increased with lower doses,
while decreased at higher doses. (2) PSA, Con A, and WGA
demonstrated augmented effects on APS that was increased at all
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FIGURE 9 | Triticum vulgaris (Succinylated) S-WGA-TRITC affected C. elegans GFP-DAergic neurons. (A) The number of GFP-DAergic neurons per animal
was similar to the effect of WGA-TRITC (7.3–7.0, n = 4, P > 0.5). (B) The fluorescence intensity was reduced from 735 ± 26 (control) to 667 ± 25 (1.11 × 10−2 and
11.12 × 10−3, n = 4, P < 0.05). (C) The size of GFP-DAergic neurons were slightly reduced at the high dose only to 9.2 ± 0.6 μm2 (11.12 × 10−2, n = 4, P = 0.4).
Direct co-localization of WGA-TRITC with GFP-DAergic neurons was not detected. S-WGA-TRITC affected the GFP-DAergic neurons in liquid culture. (D) The
number of the GFP-DAergic neurons was decrease at low doses. (E) The fluorescence intensity of the GFP-DAergic neurons was increased. (F) The size of the
GFP-DAergic neurons was decreased. (G) The APS was increased at a low dose, and decreased does-dependently at higher doses. (H) Mean survival time of each
group. * indicates statistical significance.

doses in a dose-dependent manner. (3) GSL-I and PNA decreased
the APS dose-dependently.
Neurotoxins such as botulinum toxin or ricin bind to specific
receptors on cell membrane, to be internalized, and exert toxic
effects (97, 98). Similarly, lectins bind to carbohydrate ligands
of targeted cells to be functional, producing effects. Specific
sugars may competitively bind and inhibit lectins uptake (99).
Structurally similar lectins might share similar binding receptors and compete for each other’s binding sites. The complex
GI environment, including nutrients and cellular environment,
might alter the absorption of certain lectins and their potential
biological consequences (100).
In a recent Danish report, patients who had vagal nerves
removed 20 years earlier had 40% lower incidence of PD than
control populations. If dietary proteins are one potential etiology
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for PD, by transport to neurons from the gut, as hypothesized
here, removal of the vagal nerve would have prevented or reduced
this etiology pathway. Symptoms of motor impairment are typical in PD patients, and dysfunction of aspects of the autonomic
nervous system are often underrated, such as GI motility (101),
rapid eye movement (102), and so on. The current study indicates
potential transport of some dietary plant lectins from the GI tract
to the DAergic-N in C. elegans, with direct or indirect effects on
these neurons and diverse effects on APS. This observation may
be related to the Braak and Hawkes’ hypothesized unknown etiologic agent for PD or related, for example, to damaged DAergic-N
that have been found in PD (40, 47). If related, the process may be
gradual, may be additive, related to the frequency of consumption
of certain lectins, and may be determined by the association of
lectins with other factors. Certainly, there is potential for inputs
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from individual genetic susceptibility, varying sugar structures
profiles in different cell membranes, the receptivity to endocytosis, a disorder or leakage of the GI lining, and dietary content.
Our observations are a tantalizing possible explanation for why
dietary plants have been linked to a risk of developing PD.
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